The neoplastic T cells of a series of seven patients with chronic T-cell neoplasia were tested for helper activity on pokeweed mitogen (PWM)-induced and interleukin 2 (IL-2)-induced Ig synthesis. The neoplastic T cells of all patients had a T3+4+8-1+I1 -phenotype but differed in expression of the 3A1 antigen. The neoplastic T cells of three patients had helper activity on both PWM-and IL-2-driven Ig synthesis, and in addition produced IL-2 in response to PWM stimulation. Two of these patients had hypergammaglobulinemia. In contrast, the neoplastic T cells in the remaining four patients did not produce IL-2 and did not support PWM-driven Ig synthesis. The T4' cells of these four patients, however, provided excellent helper activity on IL-2-driven Ig synthesis. These findings emphasize the role of IL-2 in T cell-dependent Ig synthesis and clearly show that IL-2 production is required for helper activity in the PWM-driven system. It is concluded that the combined use of PWM-and IL-2-driven Ig synthesis systems allows separate analysis of IL-2 production and T-helper activity in health and disease.
Introduction
The rationale for functional studies with neoplastic T cells in human proliferative diseases is dual: in the first place, they may contribute to a refined classification of the various lymphoproliferative disorders. Second, the malignant cells may represent homogeneous outgrowths of T cells that to a greater or lesser extent have retained the functional properties and phenotype of the normal counterpart T-cell subset. Clonal expansions of T cells with a mature helper phenotype in Sezary syndrome patients and in some patients with chronic T-cell lymphocytic leukemia (T-CLL)' have been reported. In only a small number ofpatients 1. Abbreviations used in this paper: ATLL, adult T-cell lymphoma/leukemia; BM, bone marrow; CLL, chronic lymphocytic leukemia; CTCL, cutaneous T-cell lymphoma; E, sheep erythrocytes; IL-2, interleukin 2; LFA-1, lymphocyte function-associated antigen-1; LN, lymph nodes; PBL, unfractionated peripheral blood leukocytes; PLL, prolymphocytic leukemia; PWM, pokeweed mitogen. the T4' cells had functional helper activity on pokeweed mitogen (PWM)-driven Ig synthesis (1) (2) (3) (4) (5) . Although the neoplastic T cells in adult T-cell lymphoma/leukemia (ATLL) patients have the helper T4+8-phenotype, the malignant T cells lack helper activity, and in a large number of patients have suppressor activity (5) (6) (7) .
It has been demonstrated that interleukin 2 (IL-2) plays an important role in T-cell-dependent Ig synthesis (8, 9) . IL-2 production is a requirement for PWM-induced Ig synthesis (8) and moreover, IL-2 itself induces Ig synthesis in a T-cell-dependent fashion (8, 9) . In the IL-2-driven system, the necessity of IL-2 production by T-helper cells is bypassed by the addition of exogenous IL-2. Analysis of helper activity in both the PWM-and the IL-2-driven system enables one to study separately two Tcell functions required for helper activity on B-cell differentiation: IL-2 synthesis and the delivery of the actual T-helper signal induced by IL-2. In contrast to "bulk" T4' populations, clonal T4' cells, derived from normal individuals in vitro (10) and from "clonal" neoplastic T4' cells of patients with mature Tcell malignancies (1 1), do not always produce IL-2 upon stimulation. In (18) . Graded numbers of T4+ cells and PBL of the patients were co-cultured with 2-4 x 104 normal non-T cells in the presence of 50 ,ug/ml PWM (Gibco, Grand Island, NY; lot no. C477102). In the same microculture system it has been shown that optimal concentrations (30 U/ml) of purified IL-2 and human recombinant IL-2 induce Ig synthesis in a T-celldependent fashion quite similar to the PWM-driven helper system (8, 9 IL-2 production. The production of IL-2 by normal control T4+ T cells and PBL of patients was evaluated under the same culture conditions as applied for the PWM-induced helper assays. After 3 d of culture, supernatants of quadruplicate cultures were pooled and stored at -20°C until tested for IL-2 activity in a proliferation assay with an IL-2-dependent murine T-cell line as indicator cells. The amounts of IL-2 are expressed in units per milliliter, one unit being defined as the amount of IL-2 that induces half-maximal proliferation in the murine T-cell line.
Results
Surface marker analysis ofpatient lymphocytes. In all patients the malignant T cells in the blood were T3+4+8-1 I', II-, LFA-1 + T cells, except in patient 7, whose neoplastic T cells did not express the T3 antigen (Table II) . The majority of the T4+ cells of patient 3 (T-CLL) and patient 6 (Sezary syndrome) did not react with a monoclonal antibody that defines the 3A 1 antigen, an antigen that is characteristically not expressed on neoplastic T4+ cells in Sezary syndrome and ATLL patients (16) . In the cases tested the tumor cells were T 17+, an antigen expressed on the majority of peripheral T cells (15) . The homogeneous marker profiles taken together with the very high lymphocyte count in the patients indicate that the PBL of the patients were virtually all tumor cells. T1   T3  T4  T6  T8  TII  T17   TAC  II   3AI   CLB-LFA-l/I   1  73  NT  88  84  NT  1  90  NT  29  NT  NT  96  2  93  88  92  93  NT  8  93  87  NT  5  94  95  3  NT  97  93  90  6  10  84  85  NT  9  21  70  4   46  89  95  95   0   5  87  88  18  7  95  97  5  98  NT  92  94  0  3  98  NT  27  2  79  98  6  NT  NT  80  90  4  0  80  70  NT  4  6  90  7  80  95  2 Neoplastic T4+ cells with helper activity on both PWM-and IL-2-driven Ig synthesis. The malignant T cells of three out of seven patients (patients 1, 2, and 3) provided helper activity on PWM-and IL-2-driven Ig synthesis. Fig. I shows the helper activity of graded numbers of PBL of patients 1, 2, 3, and 7 in the PWM-and the IL-2-driven system compared with normal T4' cells in three different experiments. The neoplastic T4' cells of patient 2 were very potent as helper cells, because a shift towards lower cell numbers in the dose-response curve in the PWM-driven system was observed with patient cells compared with normal T4' cells when very low T cell numbers were applied (Fig. 1, Exp. 3 ). Helper activity of T4' cells of patient I showed an altered dose-response curve, with an optimal helper activity at high cell numbers, compared with normal T4' cells and T4' cells of patients 2 and 3 ( Fig. 1, Exp. 1 and 2 ). As controls, T4' cells of patient 7 and of a Sezary syndrome patient (Hoe) that have been shown to be devoid of helper activity in the PWM- induced system, were arbitrarily included (Fig. 1 , Exp. 1 and Exp. 2). The T4' cells of patient 7 , in contrast to the cells of patients 1-3, only had helper activity in the IL-2-driven system (Fig. I D) . Neoplastic T4+ cells with helper activity on IL-2-driven Ig synthesis. The neoplastic T4' cells of four out of seven patients (patients [4] [5] [6] [7] in the present series did not provide or provided marginal (patient 5) helper activity on PWM-driven Ig synthesis, but provided good helper activity in the presence of exogenous IL-2 (Fig. 2) . The results ofat least three experiments demonstrate that the helper activity provided by the tumor cells of patients [4] [5] [6] [7] reached its optimum at relatively high cell numbers (Fig.  2) . For normal T4' cells the optimal Ig induction was obtained by 20,000 or 40,000 cells ( Figs. 1 and 2) .
PWM-induced IL-2 synthesis by neoplastic T4+ cells. Because IL-2 production is an essential step in PWM-induced Ig synthesis, it was then tested whether the neoplastic T4' cells ofthese seven patients in our series could produce IL-2 upon stimulation with PWM. Normal donor T4+ cells produced significant amounts in the PWM-driven system, with a peak response at day 3 (8) ( Table III) . The neoplastic T4+ cells of patients 2 and 3 produced large amounts of IL-2, whereas the T4+ cells of patient 1 produced amounts of IL-2 comparable to the amount of IL-2 produced by normal T4+ cells (Table III) . T4+ cells of patients 4-7 never produced more than 1 U/ml (data not shown).
Discussion
Functional studies with neoplastic T cells with immunoregulatory activity may add to our understanding of the regulatory mechanisms in the normal immune system (19) . Because T-cell malignancies are homogeneous, "clonal" outgrowths of a particular T-cell, they enable one to perform immunoregulatory studies at the clonal level (1, 5, 7, (18) (19) (20) . In the present study we analyzed the helper activity on T-cell-dependent Ig synthesis by normal B cells delivered by a series of seven neoplastic T4+ cell populations. Helper activity was tested in the PWM-driven system and in a culture system in which exogenous IL-2 was present, and the requirement for IL-2 production by the helper T cells was bypassed (8) .
The neoplastic T4+ cells ofthree out ofseven patients in this series had helper activity on both PWM-and IL-2-induced Ig synthesis. The neoplastic T4+ cells of one of these patients (patient 2) even had stronger helper activity than normal T4+ cells on a per cell basis in the PWM-driven system. The T4+ cells of the remaining four patients (patients 4-7) did not provide helper activity on PWM-driven Ig synthesis, but showed good helper activity on IL-2-driven Ig synthesis. Helper activity on PWMdriven Ig synthesis correlated with the capacity ofthe neoplastic T4+ cells of patients 1-3 to produce IL-2 in response to PWM stimulation. (5, 19, 22) . In a series of seven Sezary patients tested in our laboratory, no helper activity could be found in the PWM-driven system delivered by neoplastic T cells (22) . The tumor cells of only one of those patients (patient 6 in this study) had helper activity on IL-2-driven Ig synthesis. In a previous study, it was shown that the failure ofT4' cells of patient 4 to provide help in the PWM-driven system indeed was due to a failure to produce IL-2 in that system. The lack of helper activity in the PWM system could be overcome by the addition of IL-2 and was not caused by suppressive effects of Our findings indicate that IL-2 production and the capacity to provide helper activity are two distinct T-cell properties. Until now, T cell populations that provide helper activity on PWMdriven Ig synthesis without IL-2 production have not been found. Human T-cell clones have been described, however, that produced large amounts of IL-2 but had no antigen-specific helper activity, whereas other clones had strong helper activity but produced minimal amounts of IL-2 (10). It can be concluded that the use of both the IL-2-and the PWM-driven system in the study of immunoregulatory T-cell activities in health and disease enables one to separately study IL-2 production and the ability of the T cells to produce helper factors for B-cell differentiation.
